Table of contents

LETTER

• Histological evaluation of chronic pancreatitis by endoscopic ultrasound-guided fine needle biopsy (17 October, 2006)

  J Iglesias-García, I Abdulkader, J Lariño-Noia, J Forteza, J E Dominguez-Muñoz
• Severe isolated myopathic gastroparesis: a case report with pathological findings (17 October, 2006)

  H Sokol, A Lavergne-Slove, J Mikol, J M Sabate, B Coffin
• An exuberant inflammatory response to E coli: implications for the pathogenesis of ulcerative colitis and pyoderma gangrenosum

  (17 October, 2006)

  D J B Marks, F Z Rahman, M Novelli, R C Yu, S McCartney, S Bloom, A W Segal
• A pilot study in patients with established advanced liver fibrosis using pirfenidone (17 October, 2006)

  J Armendáriz-Borunda, M C Islas-Carbajal, E Meza-García, A R Rincón, S Lucano, A S Sandoval, A Salazar, J Berumen, A Alvarez, A Covarrubias, G Aréchiga, L García
• Haemorrhoids and transient receptor potential vanilloid 1 (17 October, 2006)

  F F di Mola, H Friess, J Köninger, F Selvaggi, I Esposito, M W Büchler, P di Sebastiano
• Anti-TNF-α for treatment of amyloidosis associated with Crohn’s disease (17 October, 2006)

  A Fernández-Nebro, I Ureña, M V Irigoyen, R García-Vicuña
• Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis (10 May, 2006)

  S Joossens, J-F Colombel, C Landers, D Poulain, K Geboes, X Bossuyt, S Targan, P Rutgeerts, W Reinisch
• H pylori negative MALT lymphoma patients successfully treated with antibiotics: doubts about their H pylori negativity

  (17 October, 2006)

  E Lahner, M Milione, G Delle Fave, B Annibale
• Non-invasive evaluation of hepatic fibrosis using magnetic resonance and ultrasound techniques (17 October, 2006)

  J F L Cobbold, M Wylezinska, C Cunningham, M E Crossey, H C Thomas, I J Cox, N Patel, S D Taylor-Robinson
• Safe and effective application of anti-TNF-α in a patient infected with HIV and concomitant Crohn’s disease (17 October, 2006)

  B Beltrán, P Nos, G Bastida, M Iborra, M Hoyos, J Ponce
• Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer (17 October, 2006)

  B Iacopetta, T Watanabe
• Coeliac disease: between “pizza” and ethics (17 October, 2006)

  L Elli
• The statistics of targets (17 October, 2006)

  M Heydtmann
• Balloon gastrostomy migration leading to acute pancreatitis (17 October, 2006)

  J Periselneris, R England, M Hull
• Does delayed gastric emptying really cause symptoms in functional dyspepsia? We still doubt it! (17 October, 2006)

  N J Talley, G R Locke, J Tack
• Association of tumour necrosis factor α promoter haplotype with chronic pancreatitis (29 June, 2006)

  M-C Chang, Y-T Chang, Y-W Tien, P-C Liang, S-C Wei, J-M Wong
• Lack of association of the pregnane X receptor (PXR/NR1I2) gene with inflammatory bowel disease: parallel allelic association study and gene wide haplotype analysis (17 October, 2006)

  G-T Ho, N Soranzo, S K Tate, H Drummond, E R Nimmo, A Tenesa, I D Arnott, J Satsangi
• Genetic association between factor V Leiden and coeliac disease (17 October, 2006)

  T Mari, A Zullo, C Hassan, L Di Giulio, S Morini
• Urease induced calcium precipitation by Helicobacter species may initiate gallstone formation

  (17 October, 2006)

  C Belzer, J G Kusters, E J Kuipers, A H M van Vliet
• No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population

  (17 October, 2006)

  A Franke, A Ruether, N Wedemeyer, T H Karlsen, A Nebel, S Schreiber
• Preliminary data on the use of intraductal optical coherence tomography during ERCP for investigating main pancreatic duct strictures (21 July, 2006)

  P A Testoni, A Mariani, B Mangiavillano, P G Arcidiacono, E Masci
• Prognostic value of the lymph node ratio in node positive colon cancer (17 October, 2006)

  M De Ridder, V Vinh-Hung, Y Van Nieuwenhove, A Hoorens, A Sermeus, G Storme
• Could the GI tract be a better portal for antibody therapy? (17 October, 2006)

  S J Green, Jon Brendsel
• A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon α-2b and ribavirin (17 October, 2006)

  T Watanabe, M Inoue, K Harada, N Homma, M Uchida, N Ogata, R Funada, K Hasegawa, K Soga, K Shibasaki